Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity - Wikidata - awgldk - TriplyDB

Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity

Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity

http://www.wikidata.org/entity/Q34195335

about

Cardiac catheterization: consequences for the endothelium and potential for nanomedicine.Artificial placenta: Recent advances and potential clinical applications.Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).The pathology of the foreign body reaction against biomaterials.Characterization and in vivo performance of nitric oxide-releasing extracorporeal circuits in a feline model of thrombogenicity.The effect of tadalafil therapy on kidney damage caused by sepsis in a polymicrobial septic model induced in rats: a biochemical and histopathological study Adult veno-arterial extracorporeal life support

P2860

Q38272064-B743E525-2857-48B8-B341-92D8FF1C9AE5 Q38750142-83CFA05C-FB29-4F72-BEC5-AE40E9F1A99A Q38844542-BE848830-41FD-4F36-8535-F1E34F9B194F Q38998558-01AAFA1E-7ABE-4C70-B0C1-6A32C8436FAF Q40468899-82872B0D-476B-42D6-85E2-1C9C0EFCD7C3 Q40542339-26B898B9-D4E8-4EF4-812C-B0371D4AB4EB Q57094568-BB3C1BEF-A755-45AC-9985-3910D65CAD4F

P2860

Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity

http://www.wikidata.org/entity/Q34195335

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development and hemocompatibil ...... abbit model of thrombogenicity

@ast

Development and hemocompatibil ...... abbit model of thrombogenicity

@en

Development and hemocompatibil ...... abbit model of thrombogenicity

@nl

type

label

Development and hemocompatibil ...... abbit model of thrombogenicity

@ast

Development and hemocompatibil ...... abbit model of thrombogenicity

@en

Development and hemocompatibil ...... abbit model of thrombogenicity

@nl

prefLabel

Development and hemocompatibil ...... abbit model of thrombogenicity

@ast

Development and hemocompatibil ...... abbit model of thrombogenicity

@en

Development and hemocompatibil ...... abbit model of thrombogenicity

@nl

P1433

Q34195335-0E890D3E-3D37-44DD-AD6B-B7FED057D2EA

P1476

Q34195335-435FC846-0CEC-4B1D-B224-D031F3E17D6F

P2093

Q34195335-0345C2FF-2C98-4EBD-BE5A-7DA50BC88AE0

Q34195335-0992D175-7254-4336-BA84-950179F62992

Q34195335-1E618A29-8BC4-4C21-9E44-756FB025926B

Q34195335-E40D14F6-6CCE-431B-B827-4E2CF978CE1C

P2860

Q34195335-0033A712-83BA-4234-BCAF-F1335A9F1E9F

Q34195335-082C7A8F-996E-42F0-8264-12FD27509781

Q34195335-0AD21676-CAAA-4B8A-868E-1107017A7E45

Q34195335-0E0DBC11-5D86-4C91-B029-3FC06D0CC435

Q34195335-1052E1A0-69E4-4395-B4AC-C798200CC750

Q34195335-122ACE54-AEC7-4C32-AB08-8FB4DA55C776

Q34195335-141CF468-A61A-49AB-B8E0-222CE4260647

Q34195335-154EF90E-7D15-4E60-83BF-6E63AF58B9D2

Q34195335-165314DE-66A6-438F-9C6E-D8B97A50A84F

Q34195335-17BEAC58-606F-44CD-ACE0-A5BE2508CC33

P304

Q34195335-606001D6-5044-434B-AAC3-9770239BDBC0

P31

Q34195335-7F353A5A-7B68-411C-9842-27EAB328AFA6

P356

Q34195335-ED54A2CF-2212-4285-BF4E-A8FA3DE5B330

P433

Q34195335-5DCE73DD-8708-43BF-BCEB-8B7D9AF82854

P478

Q34195335-34566BB8-1F7C-4B11-830B-11E05860A996

P577

Q34195335-2716BD4E-C26A-44DE-B23A-DD6898C26323

P698

Q34195335-A673633A-EC58-4697-BD7F-03ADFB2DAA35

P932

Q34195335-BD3B41F8-F751-4538-A226-1185379922DA

P356

0885328214538866

P1433

Journal of Biomaterials Applications

P1476

Development and hemocompatibil ...... abbit model of thrombogenicity

@en

P2093

Gail M Annich

http://www.w3.org/2001/XMLSchema#string

Hitesh Handa

http://www.w3.org/2001/XMLSchema#string

Robert H Bartlett

http://www.w3.org/2001/XMLSchema#string

Terry C Major

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet-based coagulation: different populations, different functions

The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review.

Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease

Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study

The L-arginine/NO pathway in the early phases of platelet stimulation by collagen

cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets

Blood compatibility and permeability of heparin-modified polysulfone as potential membrane for simultaneous hemodialysis and LDL removal.

Evaluation of five rapid diagnostic kits for influenza A/B virus.

Effects of systemic heparinization on the thrombogenicity of hydrophilic and nonhydrophilic catheters in a swine model.

P304

479-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0885328214538866

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24934500

http://www.w3.org/2001/XMLSchema#string

P932

4165720

http://www.w3.org/2001/XMLSchema#string